Publications by authors named "Harish Shrikrishna Bharambe"

Medulloblastoma, the most common malignant brain tumor in children, consists of four molecular subgroups WNT, SHH, Group 3, and Group 4. Group 3 has the worst survival rate among the four subgroups and is characterized by the expression of retina-specific genes. CRX, the master regulator of the photoreceptor differentiation, is aberrantly expressed in Group 3 medulloblastomas.

View Article and Find Full Text PDF

Medulloblastoma, a common pediatric malignant brain tumor, consists of four distinct molecular subgroups WNT, SHH, Group 3 and Group 4. Exome sequencing of 11 WNT subgroup medulloblastomas from an Indian cohort identified mutations in several chromatin modifier genes, including genes of the mammalian SWI/SNF complex. The genome of WNT subgroup tumors is known to be stable except for monosomy 6.

View Article and Find Full Text PDF
Article Synopsis
  • * MYC is an oncogene that stimulates the expression of miR-193a, which is absent in Group 3 tumors due to promoter hypermethylation; restoring miR-193a in these cells inhibits tumor growth and increases sensitivity to radiation.
  • * MiR-193a disrupts MYC signaling by downregulating its partners and leads to widespread gene expression repression, suggesting it could be a valuable therapeutic target for treating aggressive cancers driven by MY
View Article and Find Full Text PDF

Genome-wide expression profiling studies have identified four core molecular subgroups of medulloblastoma: WNT, SHH, Group 3 and Group 4. Molecular markers are necessary for accurate risk stratification in the non-WNT subgroups due to the underlying heterogeneity in genetic alterations and overall survival. MiR-204 expression was evaluated in molecularly classified 260 medulloblastomas from an Indian cohort and in 763 medulloblastomas from the MAGIC cohort, SickKids, Canada.

View Article and Find Full Text PDF